Creative Commons source reading · ALS and frontotemporal degeneration
CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia.
Kelly L Williams; Simon Topp; Shu Yang; Bradley Smith; Jennifer A Fifita; Sadaf T Warraich; Katharine Y Zhang; Natalie Farrawell; Caroline Vance; Xun Hu; Alessandra Chesi; Claire S Leblond; Albert Lee; Stephanie L Rayner; Vinod Sundaramoorthy; Carol Dobson-Stone; Mark P Molloy; Marka van Blitterswijk; Dennis W Dickson; Ronald C Petersen; Neill R Graff-Radford; Bradley F Boeve; Melissa E Murray; Cyril Pottier; Emily Don; Claire Winnick; Emily P McCann; Alison Hogan; Hussein Daoud; Annie Levert; Patrick A Dion; Jun Mitsui; Hiroyuki Ishiura; Yuji Takahashi; Jun Goto; Jason Kost; Cinzia Gellera; Athina Soragia Gkazi; Jack Miller; Joanne Stockton; William S Brooks; Karyn Boundy; Meraida Polak; José Luis Muñoz-Blanco; Jesús Esteban-Pérez; Alberto Rábano; Orla Hardiman; Karen E Morrison; Nicola Ticozzi; Vincenzo Silani; Jacqueline de Belleroche; Jonathan D Glass; John B J Kwok; Gilles J Guillemin; Roger S Chung; Shoji Tsuji; Robert H Brown; Alberto García-Redondo; Rosa Rademakers; John E Landers; Aaron D Gitler; Guy A Rouleau; Nicholas J Cole; Justin J Yerbury; Julie D Atkin; Christopher E Shaw; Garth A Nicholson; Ian P Blair
Originally published in Nature communications · 2016-04-15
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are overlapping, fatal neurodegenerative disorders in which the molecular and pathogenic basis remains poorly understood. Ubiquitinated protein aggregates, of which TDP-43 is a major component, are a characteristic pathological feature of most ALS and FTD patients. Here we use genome-wide linkage analysis in a large ALS/FTD kindred to identify a novel disease locus on chromosome 16p13.3. Whole-exome sequencing identified a CCNF missense mutation at this locus. Interrogation of international cohorts identified additional novel CCNF variants in familial and sporadic ALS and FTD. Enrichment of rare protein-altering CCNF variants was evident in a large sporadic ALS replication cohort. CCNF encodes cyclin F, a component of an E3 ubiquitin-protein ligase complex (SCF(Cyclin F)). Expression of mutant CCNF in neuronal cells caused abnormal ubiquitination and accumulation of ubiquitinated proteins, including TDP-43 and a SCF(Cyclin F) substrate. This implicates common mechanisms, linked to protein homeostasis, underlying neuronal degeneration.
Discussion
We performed whole-genome linkage analysis and whole-exome sequencing in one of the largest ALS/FTD pedigrees to be described in recent years. ALS/FTD was significantly linked to a single locus encompassing CCNF and exome sequencing identified a single CCNF mutation that segregated with seven affected family members. We extended mutation discovery and rare variant analysis to ALS/FTD cohorts from diverse geographic populations, most of European ancestry. Analysis in a replication cohort showed a significant enrichment of novel and rare protein-altering CCNF variants in sporadic ALS patients.
Editorial reading guide
- Was the evidence cross-sectional, longitudinal or experimental?
- How did the authors account for age, disease stage and differences among participants?
